Lantern Pharma Inc (NAS:LTRN)
$ 3.27 -0.01 (-0.3%) Market Cap: 35.20 Mil Enterprise Value: 2.27 Mil PE Ratio: 0 PB Ratio: 1.14 GF Score: 39/100

Q1 2021 Lantern Pharma Inc. Earnings Call Transcript

May 03, 2021 / 08:30PM GMT
Release Date Price: $15.98 (+6.46%)
Operator

Good afternoon, and welcome to Lantern Pharma's First Quarter 2021 Conference Call. As a reminder, this call is being recorded.

(Operator Instructions)

I would now like to introduce your host for today's conference, Marek Ciszewski with Investor Relations at Lantern Pharma. Marek, please go ahead, sir.

Marek Ciszewski

Thank you, Jim. And welcome, everyone, to the Lantern Pharma's First Quarter 2021 Conference Call. On the call today are Panna Sharma, Lanterns' President and CEO; David Margrave, Lanterns' CFO; and Dr. Kerry Barnhart, Lantern's Vice President of Clinical Development.

Our press release was issued today with our first quarter financial results that we will be discussing on our call today. Following the safe harbor statement, Panna will provide an overview of business highlights, after which David will overview our quarterly financial results, and Dr. Barnhart will provide an update on our LP-300 program. Panna will then offer concluding comments, after which we will open this call to questions.

Please also note that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot